Buscar
Mostrando ítems 21-30 de 31
Coronavirus and other airborne agents with pandemic potential
(Current opinion in environmental science and health, 2020)
The recent emergence of a novel coronavirus (severe acute respiratory syndrome coronavirus 2) has caused a pandemic, which is the most severe infectious disease outbreak in many decades. Other infective agents such as ...
Envisioning hepatitis delta cure without functional hepatitis B cure
(AIDS reviews, 2022)
[abstract not available]
Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study
(Autoimmunity Reviews, 2023)
INTRODUCTION: SARS-CoV-2 infection and COVID-19 vaccines might have increased the incidence of giant-cell arteritis (GCA) and the risk of associated stroke in Spain.
METHODS: Retrospective nation-wide observational ...
Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain
(Journal of Clinical Virology, 2023)
Background: Before the advent of COVID-19 vaccines, hospitalizations due to SARS-CoV-2 infection during 2020 collapsed most medical centers worldwide. Disruptions in health care for clinical conditions other than COVID-19 ...
Treatment of hepatitis delta and HIV infection
(Liver International, 2023)
Hepatitis delta virus (HDV) is a defective agent that only infects individuals with hepatitis B virus (HBV). Around 5–10% of chronic hepatitis B patients worldwide are superinfected with HDV, which means 15–25 million ...
Susceptibility to hepatitis B virus infection in adults living in Spain
(Liver International, 2023)
BackgroundA protective hepatitis B virus (HBV) vaccine has been available for four decades. Universal HBV vaccination of infants is recommended by the WHO since the 1990s. Furthermore, HBV immunization is advised for all ...
Safety considerations in the management of hepatitis C and HIV co-infection
(Expert Opinion on Drug Safety, 2023)
Introduction: Both HCV and HIV are highly prevalent infections with current estimates of 57 and 38 million people infected worldwide, respectively. Oral antivirals can be curative for HCV and rescue HIV patients from disease ...
The slowdown of new infections by human retroviruses has reached a plateau in Spain
(Journal of Medical Virology, 2023)
The 2022 annual meeting of the HTLV & HIV-2 Spanish Network was held in Madrid on December 14. We summarize here the main information presented and discussed at the workshop and review time trends for human retroviral ...
Another patient has cured HIV infection
(NLM (Medline), 2021)
Up to date, a sterilizing cure of HIV-1 infection has been reported in only two persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplantations from donors who were homozygous for the CCR5 Δ32 ...
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
(Elsevier B.V., 2022)
Viral hepatitis is among the top four causes of mortality globally, causing 1.4 million deaths each year, exceeding tuberculosis, malaria and human immunodeficiency virus. Hepatitis B and C are responsible for 90% of ...